Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

George Hindy(Lund University), Salim S. Hayek(Emory University), Søren Brunak(University of Copenhagen), Ayse Bilge Ozel(University of Michigan), Gunnar Engström(Lund University), Henrik Ullum, Karl C. Desch(University of Michigan), James S. Pankow(University of Minnesota), Grace H. Holton(University of Michigan), Mary E. Haas(Broad Institute), Daniel R. Goldstein(University of Michigan), Feriel Presswalla(University of Michigan), Joseph Dowsett(Copenhagen University Hospital), Sarah E. Graham(University of Michigan), Luca A. Lotta(University of Cambridge), Ole Birger Pedersen(Næstved Sygehus), Kingsley‐Michael Amadi(University of Michigan), Pennelope Blakely(University of Michigan), Lise Wegner Thørner, Sisse Rye Ostrowski(Copenhagen University Hospital), Grace Erne(University of Michigan), Karina Banasik(University of Copenhagen), Cristen J. Willer(University of Michigan), Changli Wei(University of Miami), Daniel J. Tyrrell(University of Michigan), Jesper Eugen‐Olsen(Hvidovre Hospital), Akl C. Fahed(Broad Institute), Christian Erikstrup(Aarhus University Hospital), Alexi Vasbinder(University of Washington), Jochen Reiser(University of Miami), Marju Orho‐Melander(Lund University), Lili Zhao(University of Michigan), Olle Melander, Jonas B. Nielsen(Oslo University Hospital), Venkatesh L. Murthy(Michigan Medicine), Hui Wang(Tongji Hospital), Anis Ismail(University of Michigan), Nona Sotoodehnia(University of Washington), Christopher Launius(University of Michigan), Susan R. Heckbert(University of Washington), Annika Tekmulla(University of Michigan), David J. Pinsky(Neurological Surgery)
Journal of Clinical Investigation
October 4, 2022
Cited by 70


Related Papers